Presented By Dr Mohammad Moharram
Released on 15-11-202019 year old male
Patient previously diagnosed as sickle cell anemia.
History of repeated blood transfusion last time was 5 months ago.
Referred today from a private hospital as cas of SCA in crisis with 3 attacks of convulsions. Patient has generalised bodyache.
Patient is pale and slightly jaundiced.
CBC: ً
WBC: 11.1x103 /uL (Neutrophils: 5.7x103 /uL - Lymphocytes: 3.7x103 /uL - Monocytes:1.2x103 /uL - Eosinophils: 0.4 x103 /uL -Basophils: 0.1x103 /uL)
HGB: 9 g/dL - MCV: 63.6 fL - MCH: 22.3 pG - MCHC: 34%
Platelet: 607x103 /uL
Reticulocytic count %: 6.7% - Absolute reticulocytic count: 276 xx109 /uL
LDH: 270 u/L (R.R.: 98-192)
Total Bilirubin: 56 umol/L (R.R.: 5.1-20.5) - Direct Bilitubin: 8.5 umol/L (R.R.: 1.7-8.6)
S. Ferritin: 366 ng/mL (R.R.: 30-400) - S. Iron: 31 umol/L (R.R.: 8-32) - Total iron binding capacity: 82.2 umol/L (R.R.: 45-81)
Normal Renal Functions & Normal Liver Functions
Sickle cell anemia in crisis
Peripheral Blood Smear:
Severe anemia with microcytic hypochromic RBCs. RBCs show marked anisocytosis and poikilocytosis. Target cells and sickle cells are frequently seen.
Reticulocytosis and Normoblastemia in association with elevated serum LDH & unconjugated bilirubin are features of active RBC hemolysis.
HGB HPLC:
HPLC show pattern of homozygous sickle cell disease with elevated HGB A2 (5.8%) & RBC microcytosis (with normal s.iron).
HGB F is elevated (6.8%)
HPLC show pattern of homozygous sickle cell disease. However elevated HGB A2 & RBC microcytosis (with normal s.iron) suggest the diagnosis sickle cell disease βS β+ thalassaemia. To be confirmed by genetic counseling, family study and DNA analysis.
Please correlate with the following abdominal ultrasound, Iron profile, thyroid functions, Serum Folate, Serum Vitamin B12 and genetic study.
Suggested Redding:
((( Beyond the neonatal period, compound heterozygosity for βS and β0 thalassaemia can often be distinguished from βS homozygosity on HPLC by an increased percentage of haemoglobin A 2 , reported values being usually 4 – 5.6% for S β0 thalassaemia in comparison with 1.6 – 3.6% for SS. However it should be noted that there is some overlap in A2 percentages, particularly when co - inheritance of α thalassaemia raises the A2 percentage in βS homozygotes. There is also overlap in haemoglobin F levels, which are usually 5 – 15% in compound heterozygotes. If the red cell indices are normal, βS β0 thalassaemia can be excluded, but in patients with microcytosis the differential diagnosis is between βS βS with coexisting α thalassaemia and βS β0 thalassaemia. When a precise diagnosis is important, e.g. for genetic counselling, either family studies or DNA analysis can permit a distinction. Compound heterozygotes for βS and β+ thalassaemia are readily recognized by all techniques because of the presence of haemoglobin A))), Barbra J. Bain, et al, Variant Haemoglobins - A giude to identification, 2010, P 37.
Barbra J. Bain, et al, Dacie and Lewis - Practical Haematology, 2017, P293.